Transformation of Luneau Technology delivers MML a return of 2.1x

MML has successfully exited its investment in Luneau Technology, a global leader in ophthalmological diagnostic equipment, refractive optometry equipment and equipment for opticians. The Group directly operates in 11 countries, with partners in more than 75 countries, selling its products worldwide.

MML led the investment alongside management in December 2014 (together with BNP Paribas Développement and Amundi).

The business began its journey in Israel in 1994 when current CEO Marc Abitbol founded Visionix. Following a merger with Luneau in France and Briot&Weco in Germany, the Luneau Group was formed. Luneau Technology is recognized for its disruptive technological products and strong innovative culture.

During the four-year partnership, the Group developed organically in its core markets and completed three acquisitions in France, US and China.

Marc Abitbol, Founding CEO of Luneau Technology said :

“I wish to thank the MML team for their trust and confidence in our group in 2014 and to have accompanied us in the transformation of Luneau Tech, which now enables us to pretend to an international leadership. This transformation paves the way to a new adventure with our new shareholder Caravelle towards new horizons for the group.”

Henry-Louis Mérieux, Managing Partner at MML, said:

‘’It has been a great pleasure to work together with visionary CEO Marc Abitbol and the rest of the management team to take the company to another step of its international development. We are confident that the growth story will successfully continue during the new financial partnership.”

Read more about
Share this story
Share on linkedin
Share on twitter
Share on facebook
Related news
MML backed Luneau Technology makes a strategic investment in Chinese partner Ming Sing Optical
MML backed Luneau acquires the French assets of Haag Streit
A new step for Luneau Technology

MML investor portal logins

For investors in MML Fund VI, MML Ireland I & MML Ireland II

For investors in MML Fund VII